MNDA (CT) Peptide
Product Specifications
Background
MNDA Antibody: MNDA controls the expression of MCL-1 and BCL02 in chronic lymphocytic leukemia cells. MNDA is also a useful marker in the recognition and differential diagnosis of marginal zone lymphomas. MNDA has a role in regulating programmed cell death in myeloid progenitor cells, and its down-regulation in myelodysplastic syndromes is related to granulocyte-macrophage progenitor cell sensitivity to TRAIL-induced programmed cell death.
NCBI Gene ID
4332
Swiss Prot
P41218.1
Accession Number
P41218.1
Type
Peptides
Concentration
200 ug/mL
Buffer
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Shipping Conditions
Blue Ice
Storage Conditions
Store MNDA (CT) Peptide at -20˚ C, stable for one year.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=9645P
Applications Notes
MNDA (CT) Peptideis used for blocking the activity of theMNDA (CT) Antibody
NCBI Official Name
Myeloid cell nuclear differentiation antigen
NCBI Organism
Homo sapiens
Background Reference 01
Bottari et al. Exp Hematol. 2020; 88:68-82
Background Reference 02
Wang et al. Am. J. Clin. Pathol. 2019; 151 (3) :337-343
Background Reference 03
Kanellis et al. Lukemia 2019; 23 (10) :1847-1857
Background Reference 04
Briggs et al. Cancer Res. 2006; 66 (9) : 4645-4651
Other Product Names
MNDA
Tested Applications
Blocking
Species
Human
Protein ID
730038
Physical Properties
Liquid
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9002951 Inquire
Rabbit anti-Escherichia coli O6:H1 (strain CFT073/700928/UPEC) MDTJ Polyclonal Antibody
Ask
View Details 